Universal Beteiligungs und Servicegesellschaft mbH lifted its stake in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 4.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 204,533 shares of the technology company’s stock after acquiring an additional 9,107 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH owned 0.12% of Veeva Systems worth $60,932,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also bought and sold shares of the company. Trust Co. of Toledo NA OH bought a new position in shares of Veeva Systems during the 2nd quarter valued at about $29,000. OLD Second National Bank of Aurora acquired a new stake in shares of Veeva Systems during the 3rd quarter valued at $30,000. Legacy Investment Solutions LLC bought a new stake in shares of Veeva Systems during the 2nd quarter worth $32,000. Maseco LLP acquired a new position in shares of Veeva Systems in the 2nd quarter worth $35,000. Finally, Cary Street Partners Investment Advisory LLC raised its position in shares of Veeva Systems by 58.3% during the second quarter. Cary Street Partners Investment Advisory LLC now owns 133 shares of the technology company’s stock worth $38,000 after purchasing an additional 49 shares during the period. Institutional investors own 88.20% of the company’s stock.
Insider Transactions at Veeva Systems
In other news, insider Thomas D. Schwenger sold 1,000 shares of the business’s stock in a transaction dated Tuesday, January 13th. The shares were sold at an average price of $231.43, for a total transaction of $231,430.00. Following the transaction, the insider owned 23,204 shares in the company, valued at approximately $5,370,101.72. The trade was a 4.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 10.30% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
Read Our Latest Research Report on Veeva Systems
Veeva Systems Stock Up 1.7%
VEEV opened at $219.83 on Thursday. The stock’s 50 day moving average price is $235.35 and its two-hundred day moving average price is $267.73. The firm has a market capitalization of $36.14 billion, a P/E ratio of 42.77, a price-to-earnings-growth ratio of 1.60 and a beta of 1.07. Veeva Systems Inc. has a 12-month low of $201.54 and a 12-month high of $310.50.
Veeva Systems (NYSE:VEEV – Get Free Report) last posted its quarterly earnings data on Thursday, November 20th. The technology company reported $2.04 earnings per share for the quarter, beating the consensus estimate of $1.95 by $0.09. Veeva Systems had a return on equity of 13.68% and a net margin of 27.93%.The company had revenue of $0.81 million during the quarter, compared to analysts’ expectations of $792.37 million. During the same period in the prior year, the business earned $1.75 earnings per share. Veeva Systems’s revenue for the quarter was up 16.0% compared to the same quarter last year. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS and its Q4 2026 guidance at 1.920-1.920 EPS. As a group, analysts anticipate that Veeva Systems Inc. will post 4.35 earnings per share for the current year.
Veeva Systems announced that its board has authorized a share repurchase plan on Monday, January 5th that authorizes the company to buyback $2.00 billion in outstanding shares. This buyback authorization authorizes the technology company to purchase up to 5.5% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its shares are undervalued.
Veeva Systems Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Recommended Stories
- Five stocks we like better than Veeva Systems
- Wall Street Alert: Buy AES
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Trump’s Hand-Written Letter Will Shock his Haters
- Your Bank Account Is No Longer Safe
- Bitcoin is down but your income is about to explode
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
